Ejaculation 发表于 2025-3-21 17:49:57

书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways影响因子(影响力)<br>        http://impactfactor.cn/2024/if/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways影响因子(影响力)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways网络公开度<br>        http://impactfactor.cn/2024/at/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways网络公开度学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways被引频次<br>        http://impactfactor.cn/2024/tc/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways被引频次学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways年度引用<br>        http://impactfactor.cn/2024/ii/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways年度引用学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways读者反馈<br>        http://impactfactor.cn/2024/5y/?ISSN=BK0828448<br><br>        <br><br>书目名称Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways读者反馈学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=BK0828448<br><br>        <br><br>

不愿 发表于 2025-3-21 22:05:01

http://reply.papertrans.cn/83/8285/828448/828448_2.png

草率女 发表于 2025-3-22 04:21:55

https://doi.org/10.1007/978-3-319-67932-7Anti-cancer; Kinases; Resistance; Tyrosine; therapeutics

Perineum 发表于 2025-3-22 04:46:20

http://reply.papertrans.cn/83/8285/828448/828448_4.png

拾落穗 发表于 2025-3-22 11:38:31

http://reply.papertrans.cn/83/8285/828448/828448_5.png

放肆的你 发表于 2025-3-22 14:54:56

http://reply.papertrans.cn/83/8285/828448/828448_6.png

光明正大 发表于 2025-3-22 19:54:00

http://reply.papertrans.cn/83/8285/828448/828448_7.png

植物学 发表于 2025-3-23 00:08:09

RAF, MEK and ERK Inhibitors as Anti-Cancer Drugs: Intrinsic and Acquired Resistance as a Major Therd cancers. Several resistance mechanisms have been proposed up to date, which result from either preexisting mechanisms in some or all cells within the tumors or due to drug-induced mechanisms. These include (a) expression of drug-resistant RAF isoforms (b) molecular or genetic alterations of downst

reperfusion 发表于 2025-3-23 01:53:42

http://reply.papertrans.cn/83/8285/828448/828448_9.png

渗入 发表于 2025-3-23 07:04:04

http://reply.papertrans.cn/83/8285/828448/828448_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways; Yosef Yarden,Moshe Elkabets Book 2018